MassMutual Private Wealth & Trust’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
RG
CDDEC
BTCPP
AAMU
ISS
MassMutual Private Wealth & Trust's AZN Position: Q2 2026 in Review
MassMutual Private Wealth & Trust reduced its AstraZeneca (AZN) stake by 6.9% in Q2 2026, selling an estimated $48.3K and leaving 3,467 shares worth $657K. The position accounts for 0.02% of the portfolio, ranked #285.
MassMutual Private Wealth & Trust first reported a position in AZN in Q4 2013 and has held it in 15 quarters since. The position peaked at $734K in Q1 2026. 679 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- MassMutual Private Wealth & Trust held 3,467 shares of AstraZeneca worth $657K as of Q2 2026.
- MassMutual Private Wealth & Trust sold 257 AstraZeneca shares in Q2 2026, an estimated $48.3K.
- AstraZeneca made up 0.02% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #285 holding.
- MassMutual Private Wealth & Trust first reported a position in AstraZeneca in Q4 2013 and has held it in 15 quarters since.
- MassMutual Private Wealth & Trust's AstraZeneca position peaked at $734K in Q1 2026.
- 679 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.